Feedback / Questions
Breyanzi (lisocabtagene maraleucel) - BMS
anti-CD19 CAR-T cell therapy - Genechem
https://www.targetedonc.com/view/car-t-cell-therapy-shows-consistent-safety-and-pharmacokinetics-in-lbcl
Apr 13, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next